Tag: critical limb ischemia (CLI)

cell therapy

Cipla & Stempeutics collaborate for launch of Stempeucel

0
Cipla announced that its partner Stempeutics Research has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel...

This function has been disabled for HealthTekPak.

error: Content is protected !!